Blood Test Predicts Melanoma Recurrence

Blood Test Predicts Melanoma Recurrence

Source: Medscape

Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in patients with resected melanoma.

TOPLINE:
Droplet digital polymerase chain reaction (PCR) measurements of circulating tumor DNA (ctDNA) identify patients with stage III melanoma who are at high risk for early recurrence during adjuvant targeted therapy. The blood-based biomarker out… [4080 chars]

Read more